Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study*

By Réa-Neto Álvaro   Niederman Michael   Margareth Lobo Suzana   Schroeder Eric   Lee Michael   Kaniga Koné   Ketter Nzeera   Prokocimer Philippe   Friedland Ian  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2113-2126

Informa Healthcare

Access to resources Recommend Favorite

Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study

By Sanz Miguel A.   Bermúdez Arancha   Rovira Montserrat   Besalduch Juan   Pascual Maria-Jesus   Nocea Gonzalo   Sanz-Rodríguez César    

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 645-656

Informa Healthcare

Access to resources Recommend Favorite

Piperacillin/tazobactam in treatment of brain abscess

By Javad Ameli   Vahid Pourfarziani   Kazem Ghoddousi   Alireza Saadat   Gholamali Ghorbani   Qulamreza Karami  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 3, 2006-03 ,pp. : 224-226

Informa Healthcare

Access to resources Recommend Favorite

Vitamin T overdose?: examining the phenomenon of widespread use of the broad spectrum antimicrobial piperacillin/tazobactam

By  

INTERNAL MEDICINE JOURNAL, Vol. 46, Iss. 9, 2016-09 ,pp. : 1116-1117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam

By He Zhong-Fang   Wu Xin-An   Wang Yan-Ping  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 11, 2013-11 ,pp. : 885-887

Informa Healthcare

Access to resources Recommend Favorite